Cigna Group posted first‑quarter revenue of $68.49 billion, a 5% rise year‑over‑year, driven by expanding pharmacy‑benefit operations under Evernorth. The health insurer’s earnings climbed to $1.65 billion, or $6.26 per share, outpacing the $1.32 billion and $4.85 per share recorded a year earlier.

Analysts had penciled in $66.29 billion in revenue, so the top‑line beat underscores the market’s appetite for integrated benefits platforms. Adjusted earnings per share hit $7.79, nudging past the FactSet consensus of $7.60. Evernorth’s growth helped cushion the impact of Cigna’s 2023 divestiture of its Medicare and related businesses, signaling that the strategic pivot is bearing fruit.

Investors responded positively, with the stock edging higher on the earnings release. The stronger profit margin reflects cost efficiencies achieved after shedding legacy Medicare assets, while the Evernorth segment continues to capture a larger share of employer‑sponsored pharmacy spend.

Cigna’s results illustrate that its bet on a benefits‑focused model is translating into tangible financial upside, positioning the company for continued earnings momentum as health‑care payers prioritize cost‑containment solutions.